Cargando…
Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions
Coronavirus disease 19 (COVID-19) is currently a global pandemic that affects patients with other pathologies. Here, we investigated the influence of treatments for osteoporosis and other non-inflammatory rheumatic conditions, such as osteoarthritis and fibromyalgia, on COVID-19 incidence. To this e...
Autores principales: | Blanch-Rubió, Josep, Soldevila-Domenech, Natalia, Tío, Laura, Llorente-Onaindia, Jone, Ciria-Recasens, Manuel, Polino, Luciano, Gurt, Alba, de la Torre, Rafael, Maldonado, Rafael, Monfort, Jordi, Group, the Covidmar Study |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655189/ https://www.ncbi.nlm.nih.gov/pubmed/33080571 http://dx.doi.org/10.18632/aging.104117 |
Ejemplares similares
-
COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments
por: Soldevila-Domenech, Natalia, et al.
Publicado: (2020) -
Reumataxi: An experience of solidarity in times of COVID-19()
por: Blanch-Rubió, Josep, et al.
Publicado: (2022) -
Reumataxi: una experiencia solidaria en tiempos de COVID-19
por: Blanch-Rubió, Josep, et al.
Publicado: (2022) -
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
por: La Porta, Carmen, et al.
Publicado: (2015) -
Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)